Timothy Coughlin - 09 Jun 2026 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Reporting relationship: Director
Issuer ticker: VIR
Reported as of: 09 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2026, 18:21:32 UTC
Prior SEC filing: 03 Jun 2026
Next SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Vanina de Verneuil, Attorney-In-Fact

Key filing fact

Timothy Coughlin filed Form 4 for Vir Biotechnology, Inc. (VIR) on 10 Jun 2026.

Key facts

This page summarizes Timothy Coughlin's Form 4 filing for Vir Biotechnology, Inc. (VIR).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 10 Jun 2026, 18:21.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001376043 Primary reporting owner

Coughlin Timothy

Relationship: Director
Address: C/O VIR BIOTECHNOLOGY, INC., 1800 OWENS STREET, SUITE 900, SAN FRANCISCO
Signature: /s/ Vanina de Verneuil, Attorney-In-Fact
Signature date: 10 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VIR transaction

Common Stock

Award

Transaction value
Shares: +8,000
Change %
Price: $0.000000^*
Shares after: 8,000
Date: 09 Jun 2026
Ownership: Direct
Footnotes: F1, F2

VIR transaction

Common Stock

Award

Transaction value
Shares: +8,000
Change %: +100%
Price: $0.000000^*
Shares after: 16,000
Date: 09 Jun 2026
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VIR transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +16,000
Change %
Price: $0.000000^*
Shares after: 16,000
Date: 09 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,000
Exercise price: $8.51
Footnotes: F4

VIR transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +16,000
Change %
Price: $0.000000^*
Shares after: 16,000
Date: 09 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,000
Exercise price: $8.51
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.

Footnote F2

1/3 of the RSUs will vest on June 9, 2027, and the remaining RSUs will vest in two equal annual installments thereafter.

Footnote F3

The RSUs will vest in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.

Footnote F4

1/3 of the shares subject to the stock option will vest and become exercisable on June 9, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter.

Footnote F5

The shares subject to the stock option vest and become exercisable in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.